메뉴 건너뛰기




Volumn 16, Issue 3, 2012, Pages 286-293

Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection

Author keywords

acute rejection; alemtuzumab; pediatric; renal transplantation

Indexed keywords

ALEMTUZUMAB; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CREATININE; DACLIZUMAB; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 84859729691     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01615.x     Document Type: Article
Times cited : (18)

References (40)
  • 2
    • 0033134958 scopus 로고    scopus 로고
    • Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation
    • Fujisawa M, Ono H, Isotani S, et al., Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation. Transplant Proc 1999: 31: 1687-1690.
    • (1999) Transplant Proc , vol.31 , pp. 1687-1690
    • Fujisawa, M.1    Ono, H.2    Isotani, S.3
  • 3
    • 0026558834 scopus 로고
    • Histopathologic findings in well-functioning, long-term renal allografts
    • Isoniemi HM, Krogerus L, Von Willebrand E, et al., Histopathologic findings in well-functioning, long-term renal allografts. Kidney Int 1992: 41: 155-160.
    • (1992) Kidney Int , vol.41 , pp. 155-160
    • Isoniemi, H.M.1    Krogerus, L.2    Von Willebrand, E.3
  • 4
    • 33744796811 scopus 로고    scopus 로고
    • Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques
    • Mehia M, Matheson PJ, Merrilees MJ, et al., Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology (Carlton) 2006: 11: 261-266.
    • (2006) Nephrology (Carlton) , vol.11 , pp. 261-266
    • Mehia, M.1    Matheson, P.J.2    Merrilees, M.J.3
  • 5
    • 10944268996 scopus 로고    scopus 로고
    • Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study
    • Schwarz A, Mengel M, Gwinner W, et al., Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005: 67: 341-348.
    • (2005) Kidney Int , vol.67 , pp. 341-348
    • Schwarz, A.1    Mengel, M.2    Gwinner, W.3
  • 7
    • 33646384606 scopus 로고    scopus 로고
    • Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data
    • Webster AC, Pankhurst T, Rinaldi F, et al., Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data. Transplantation 2006: 81: 953-965.
    • (2006) Transplantation , vol.81 , pp. 953-965
    • Webster, A.C.1    Pankhurst, T.2    Rinaldi, F.3
  • 8
    • 0032490341 scopus 로고    scopus 로고
    • Prope tolerance, perioperative Campath-1H, and low-dose cyclosporin monotherapy in renal allograft recipients
    • Calne R, Friend P, Moffatt S, et al., Prope tolerance, perioperative Campath-1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998: 351: 1701-1702.
    • (1998) Lancet , vol.351 , pp. 1701-1702
    • Calne, R.1    Friend, P.2    Moffatt, S.3
  • 9
    • 1942454828 scopus 로고    scopus 로고
    • Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients
    • Knechtle SJ,. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients. Pediatr Transplant 2004: 8: 106-112.
    • (2004) Pediatr Transplant , vol.8 , pp. 106-112
    • Knechtle, S.J.1
  • 10
    • 20544458513 scopus 로고    scopus 로고
    • Alemtuzumab (Campath-1H) induction therapy in cadaveric kidney transplantationâEfficacy and safety at five years
    • Watson CJ, Bradley JA, Friend PJ, et al., Alemtuzumab (Campath-1H) induction therapy in cadaveric kidney transplantationâEfficacy and safety at five years. Am J Transplant 2005: 5: 1347.
    • (2005) Am J Transplant , vol.5 , pp. 1347
    • Watson, C.J.1    Bradley, J.A.2    Friend, P.J.3
  • 11
    • 67649603468 scopus 로고    scopus 로고
    • Alemtuzumab as induction therapy in renal transplantation
    • Clatworthy MR, Watson CJE,. Alemtuzumab as induction therapy in renal transplantation. Trends Transplant 2008: 2: 12.
    • (2008) Trends Transplant , vol.2 , pp. 12
    • Clatworthy, M.R.1    Watson, C.J.E.2
  • 12
    • 58849135828 scopus 로고    scopus 로고
    • Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4 year experience
    • Tan H, Donaldson J, Ellis D, et al., Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4 year experience. Transplantation 2008: 86: 1725-1731.
    • (2008) Transplantation , vol.86 , pp. 1725-1731
    • Tan, H.1    Donaldson, J.2    Ellis, D.3
  • 13
    • 0028800590 scopus 로고
    • Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody
    • Friend PJ, Rebello P, Oliveira D, et al., Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody. Transplant Proc 1995: 27: 869.
    • (1995) Transplant Proc , vol.27 , pp. 869
    • Friend, P.J.1    Rebello, P.2    Oliveira, D.3
  • 15
    • 21844454963 scopus 로고    scopus 로고
    • Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients
    • Csapo Z, Benavides-Viveros C, Podder H, et al., Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients. Transplant Proc 2005: 37: 2032.
    • (2005) Transplant Proc , vol.37 , pp. 2032
    • Csapo, Z.1    Benavides-Viveros, C.2    Podder, H.3
  • 16
    • 65549147185 scopus 로고    scopus 로고
    • Alemtuzumab (Campath-1H) for the treatment of acute rejection in kidney transplant recipients: Long-term follow-up
    • Clatworthy MR, Friend PJ, Calne RY, et al., Alemtuzumab (Campath-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up. Transplantation 2009: 87: 1092-1095.
    • (2009) Transplantation , vol.87 , pp. 1092-1095
    • Clatworthy, M.R.1    Friend, P.J.2    Calne, R.Y.3
  • 17
    • 17844363736 scopus 로고    scopus 로고
    • Reversal of acute cellular rejection after renal transplantation with Campath-1H
    • Basu A, Ramkumar M, Tan HP, et al., Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc 2005: 37: 923.
    • (2005) Transplant Proc , vol.37 , pp. 923
    • Basu, A.1    Ramkumar, M.2    Tan, H.P.3
  • 18
    • 20544434671 scopus 로고    scopus 로고
    • Campath 1-H use in pediatric renal transplantation
    • Bartosh SM, Knechtle S, Sollinger H,. Campath 1-H use in pediatric renal transplantation. Am J Transplant 2005: 5: 1569-1573.
    • (2005) Am J Transplant , vol.5 , pp. 1569-1573
    • Bartosh, S.M.1    Knechtle, S.2    Sollinger, H.3
  • 19
    • 40449101372 scopus 로고    scopus 로고
    • Banff 07 classification or renal allograft pathology: Updates and future directions
    • Solez K, Colvin RB, Racusen LC, et al., Banff 07 classification or renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-776.
    • (2008) Am J Transplant , vol.8 , pp. 753-776
    • Solez, K.1    Colvin, R.B.2    Racusen, L.C.3
  • 20
    • 0035140912 scopus 로고    scopus 로고
    • Steroid-resistant kidney transplant rejection: Diagnosis and treatment
    • Bock HA,. Steroid-resistant kidney transplant rejection: Diagnosis and treatment. J Am Soc Nephrol 2001: 17: s48-s52.
    • (2001) J Am Soc Nephrol , vol.17
    • Bock, H.A.1
  • 21
    • 70350131763 scopus 로고    scopus 로고
    • De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure
    • Hidalgo LG, Campbell PM, Sis B, et al., De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009: 9: 2532-2541.
    • (2009) Am J Transplant , vol.9 , pp. 2532-2541
    • Hidalgo, L.G.1    Campbell, P.M.2    Sis, B.3
  • 22
    • 0024383936 scopus 로고
    • Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy
    • Lui SF, Sweny P, Scoble JE, et al., Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant 1989: 4: 387-389.
    • (1989) Nephrol Dial Transplant , vol.4 , pp. 387-389
    • Lui, S.F.1    Sweny, P.2    Scoble, J.E.3
  • 23
    • 0021816056 scopus 로고
    • A randomized trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
    • O rtho M ulticenter T ransplant S tudy G roup
    • O rtho M ulticenter T ransplant S tudy G roup. A randomized trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 1985: 313: 337-342.
    • (1985) N Engl J Med , vol.313 , pp. 337-342
  • 24
    • 0345676502 scopus 로고    scopus 로고
    • Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
    • Gaber AO, First MR, Tesi RJ, et al., Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998: 66: 29.
    • (1998) Transplantation , vol.66 , pp. 29
    • Gaber, A.O.1    First, M.R.2    Tesi, R.J.3
  • 25
    • 67650651210 scopus 로고    scopus 로고
    • Successful rescue of late-onset acute T-cell mediated rejection with anti-CD25 antibody: A case report
    • Osawa T, Harada H, Miura M, et al., Successful rescue of late-onset acute T-cell mediated rejection with anti-CD25 antibody: A case report. Clin Transplant 2009: 23 (Suppl 20): 31-33.
    • (2009) Clin Transplant , vol.23 , Issue.SUPPL. 20 , pp. 31-33
    • Osawa, T.1    Harada, H.2    Miura, M.3
  • 26
    • 28444460281 scopus 로고    scopus 로고
    • Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review
    • Denhaerynck K, Dobbels F, Cleemput I, et al., Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: A literature review. Transpl Int 2005: 18: 1121-1133.
    • (2005) Transpl Int , vol.18 , pp. 1121-1133
    • Denhaerynck, K.1    Dobbels, F.2    Cleemput, I.3
  • 27
    • 0028569493 scopus 로고
    • Late-acute renal allograft rejection and symptomless cytomegalovirus infection
    • Reinke P, Lippert J, Ewert R, et al., Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet 1994: 344: 1737-1738.
    • (1994) Lancet , vol.344 , pp. 1737-1738
    • Reinke, P.1    Lippert, J.2    Ewert, R.3
  • 28
    • 0035959321 scopus 로고    scopus 로고
    • Association between Epstein-barr virus infection and late acute rejection in long-term transplant patients
    • Babel N, Schwarzmann F, Prang N, et al., Association between Epstein-barr virus infection and late acute rejection in long-term transplant patients. Transplantation 2001: 72: 736-739.
    • (2001) Transplantation , vol.72 , pp. 736-739
    • Babel, N.1    Schwarzmann, F.2    Prang, N.3
  • 29
    • 0037467793 scopus 로고    scopus 로고
    • Early versus late acute rejection episodes in renal transplantation
    • Sijpkens Y, Doxiadis I, Mallat M, et al., Early versus late acute rejection episodes in renal transplantation. Transplantation 2003: 75: 204-208.
    • (2003) Transplantation , vol.75 , pp. 204-208
    • Sijpkens, Y.1    Doxiadis, I.2    Mallat, M.3
  • 30
    • 0013005599 scopus 로고    scopus 로고
    • HLA class i residue mismatch and renal graft outcome
    • Piazza A, Canossi A, Buonomo O, et al., HLA class I residue mismatch and renal graft outcome. Transpl Int 2000: 13 (Suppl 1): S444-S448.
    • (2000) Transpl Int , vol.13 , Issue.SUPPL. 1
    • Piazza, A.1    Canossi, A.2    Buonomo, O.3
  • 31
    • 67650475370 scopus 로고    scopus 로고
    • Melatonin - A pleotropic molecule involved in pathophysiological processes following organ transplantation
    • Fildes JE, Yonan N, Keevil BG, et al., Melatonin-a pleotropic molecule involved in pathophysiological processes following organ transplantation. Immunology 2009: 127: 443-449.
    • (2009) Immunology , vol.127 , pp. 443-449
    • Fildes, J.E.1    Yonan, N.2    Keevil, B.G.3
  • 32
    • 71249107177 scopus 로고    scopus 로고
    • Late acute kidney transplant rejection: Clinicopathological correlates and response to corticosteroid therapy
    • Nair R, Agrawal N, Lebaeau M, et al., Late acute kidney transplant rejection: Clinicopathological correlates and response to corticosteroid therapy. Transplant Proc 2009: 41: 4150-4153.
    • (2009) Transplant Proc , vol.41 , pp. 4150-4153
    • Nair, R.1    Agrawal, N.2    Lebaeau, M.3
  • 33
    • 33746168208 scopus 로고    scopus 로고
    • Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation
    • Sun Q, Liu ZH, Ji S, et al., Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation. Kidney Int 2006: 70: 377-383.
    • (2006) Kidney Int , vol.70 , pp. 377-383
    • Sun, Q.1    Liu, Z.H.2    Ji, S.3
  • 34
    • 79954435397 scopus 로고    scopus 로고
    • Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation
    • Shenoy M, Roberts D, Plant ND, et al., Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation. Pediatr Nephrol 2011: 26: 815-818.
    • (2011) Pediatr Nephrol , vol.26 , pp. 815-818
    • Shenoy, M.1    Roberts, D.2    Plant, N.D.3
  • 35
    • 58849136282 scopus 로고    scopus 로고
    • Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection
    • Everly MJ, Everly JJ, Susskind B, et al., Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 2008: 86: 1754.
    • (2008) Transplantation , vol.86 , pp. 1754
    • Everly, M.J.1    Everly, J.J.2    Susskind, B.3
  • 36
    • 0032914706 scopus 로고    scopus 로고
    • Anti-lymphocyte antibodies late in the course of pediatric renal transplantation
    • Butani L, Polinsky MS, Kaiser BA, et al., Anti-lymphocyte antibodies late in the course of pediatric renal transplantation. Pediatr Nephrol 1999: 13: 192-194.
    • (1999) Pediatr Nephrol , vol.13 , pp. 192-194
    • Butani, L.1    Polinsky, M.S.2    Kaiser, B.A.3
  • 37
    • 0032846748 scopus 로고    scopus 로고
    • Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-center Study Group
    • Regan JF, Campbell K, Van Smith L, et al., Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-center Study Group. Transpl Immunol 1999: 7: 115-121.
    • (1999) Transpl Immunol , vol.7 , pp. 115-121
    • Regan, J.F.1    Campbell, K.2    Van Smith, L.3
  • 38
    • 0035881990 scopus 로고    scopus 로고
    • Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin in renal transplant recipients
    • Luke PW, Scantlebury VP, Jordan ML, et al., Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin in renal transplant recipients. Transplantation 2001: 72: 419-422.
    • (2001) Transplantation , vol.72 , pp. 419-422
    • Luke, P.W.1    Scantlebury, V.P.2    Jordan, M.L.3
  • 39
    • 68849105740 scopus 로고    scopus 로고
    • Role of NK and NKT cells in solid organ transplantation
    • Pratschke J, Stauch D, Kotsch K,. Role of NK and NKT cells in solid organ transplantation. Transpl Int 2009: 22: 859-868.
    • (2009) Transpl Int , vol.22 , pp. 859-868
    • Pratschke, J.1    Stauch, D.2    Kotsch, K.3
  • 40
    • 65549090058 scopus 로고    scopus 로고
    • Targeting of Natural Killer cells by rabbit antithymocyte globulin and Campath- 1H: Similar effects independent of specificity
    • Stauch D, Dernier A, Volk HDD, et al., Targeting of Natural Killer cells by rabbit antithymocyte globulin and Campath- 1H: Similar effects independent of specificity. PLoS ONE 2009: 4: e4709.
    • (2009) PLoS ONE , vol.4
    • Stauch, D.1    Dernier, A.2    Volk, H.D.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.